Wells Fargo & Company »

Kinnate Biopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $334 141 2.37
2023-09-30 $188 134 1.40
2023-06-30 $367 121 3.03
2022-12-31 $1.8k 302 6.10
2022-06-30 $4.0k 285 14.04
2022-03-31 $14k 1.2k 11.56
2021-12-31 $212k 12k 17.75
2021-09-30 $999 46 21.74
2021-06-30 $3.0k 139 21.58
2021-03-31 $131k 4.2k 31.07